From a single lab, Amgen has grown into a global organization with over 27,000 employees, reaching nearly 10 million patients across more than 100 markets each year.
The CIIE is a platform for Amgen to showcase R&D capabilities, innovative therapies, and disease management solutions.
Amgen strives to ensure China's participation in its global research and development programs, which helps to achieve simultaneous filing and approval.
A customized collection of grant news from foundations and the federal government from around the Web.
Nonprofit impact investing firm, Acumen, has invested $1.2 million to KZ Noir, a Rwanda-based coffee processing company owned by Kaizen Venture Partners. The investment will equip KZ Noir the funds for working capital, debt refinancing, and capacity expansion.